세계의 알레르기 치료제 시장 : 유형별, 치료법별, 유통 채널별 예측(2025-2030년)

The Allergy Drugs Market was valued at USD 29.71 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 8.48%, to USD 52.54 billion by 2030.

The scope of allergy drugs encompasses a wide range of medications used to treat allergic reactions, including antihistamines, corticosteroids, decongestants, and epinephrine, among others. These drugs cater to various types of allergies such as seasonal allergies, food allergies, and allergic asthma. The necessity of these medications is underscored by the rising prevalence of allergies globally, driven by urbanization, increased pollution levels, and changing dietary patterns. In terms of application, allergy drugs are used in both over-the-counter and prescription forms to relieve symptoms like sneezing, itching, and swelling. End-use sectors include hospitals, clinics, and homecare settings, supported by a variety of delivery forms such as oral tablets, nasal sprays, inhalers, and lotions.

Market growth is influenced by factors like continuous advancements in biotechnology and genetic research, which contribute to newer and more effective allergy treatments. Additionally, growing awareness and diagnosis rates further enhance market expansion. However, the market faces challenges such as side effects associated with long-term usage of these drugs, high costs of advanced medications, and stringent regulatory requirements for new drug approval. Potential opportunities exist in expanding into emerging markets where healthcare infrastructures are improving and awareness around allergies is rising. Innovations in immunotherapy and biologic drugs represent untapped areas where companies could focus research efforts.

Companies could explore personalized medicine approaches to target specific types of allergies based on genetic predispositions. Additionally, there is room for innovation in delivery mechanisms, such as more efficient and patient-friendly administration methods like auto-injectors or nanotechnology-based delivery systems. The nature of the allergy drugs market is competitive, with both generic and branded drugs vying for market share. Initiatives in research focused on identifying new allergens and improving environmental controls could further bolster the market and provide avenues for significant business growth. Addressing these limitations and challenges with innovative solutions is crucial for continued market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Drugs Market

The Allergy Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of allergy globally
  • Increasing development of allergy-specific drugs
  • Rise in prevalence towards over the counter drugs
• Market Restraints
  • Concerns over patent expiration and extensive competition from generic drugs
• Market Opportunities
  • Introduction of immunotherapy and development of increasing ways of administration
  • Rising consumer awareness on food allergies
• Market Challenges
  • Availability of alternative drugs for allergy

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Drugs Market

A detailed market share analysis in the Allergy Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Drugs Market

A strategic analysis of the Allergy Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.

Market Segmentation & Coverage

This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Drug Allergy, Food Allergy, and Inhaled Allergy.
• Based on Treatment, market is studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).
• Based on Distribution Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of allergy globally
    • 5.1.1.2. Increasing development of allergy-specific drugs
    • 5.1.1.3. Rise in prevalence towards over the counter drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
    • 5.1.3.2. Rising consumer awareness on food allergies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative drugs for allergy
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Allergy Drugs Market, by Type

• 6.1. Introduction
• 6.2. Drug Allergy
• 6.3. Food Allergy
• 6.4. Inhaled Allergy

7. Allergy Drugs Market, by Treatment

• 7.1. Introduction
• 7.2. Anti-allergy Drugs
  • 7.2.1. Antihistamines
  • 7.2.2. Corticosteroids
  • 7.2.3. Leukotriene Inhibitors
• 7.3. Immunotherapy
  • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Allergy Drugs Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Allergy Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Allergy Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Allergy Therapeutics PLC
• 2. Astra Biotech GmbH
• 3. AstraZeneca PLC
• 4. Bayer AG
• 5. GlaxoSmithKline PLC
• 6. HAL Allergy B.V.
• 7. Hikma Pharmaceuticals PLC
• 8. Johnson & Johnson Services, Inc.
• 9. LETI Pharma, S.L.U.
• 10. Lupin Limited
• 11. Mylan N.V. by Viatris Inc.
• 12. Novartis AG
• 13. Sanofi SA
• 14. Teva Pharmaceutical Industries Ltd.
• 15. XOLAIR by F. Hoffmann-La Roche AG